Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_assertion description "[Downregulation of hemangiogenesis and lymphangiogenesis inhibitors VEGFR-1 and sVEGFR-2, and upregulation of angiogenic activators VEGF-A and VEGF-D in MYCN-amplified stage IV neuroblastoma supports the crucial effect of this oncogene on neuroblastoma progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_assertion evidence source_evidence_literature NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_assertion SIO_000772 20179233 NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_assertion wasDerivedFrom befree-2016 NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_assertion wasGeneratedBy ECO_0000203 NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.
- befree-2016 importedOn "2016-02-19" NP795646.RACq830VI_3j5bMINd7szoNbaVYXPbmUR1h0JGXx9ShyU130_provenance.